STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[SCHEDULE 13D/A] Lifeway Foods Inc SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13D/A

Rhea-AI Filing Summary

Schedule 13D/A (Amendment No. 24) – Lifeway Foods, Inc. (NASDAQ: LWAY)

The filing updates the ownership positions and intentions of the Smolyansky family and related trust. Three reporting persons disclose the following beneficial holdings, calculated against 15,203,241 outstanding shares as of 6 May 2025:

  • Edward Smolyansky: 3,159,975 shares (20.8%) – sole voting power over 2,584,975 and shared voting power over 575,000.
  • Ludmila Smolyansky: 940,166 shares (6.2%) – sole voting power over 865,166 and shared over 75,000.
  • The Edward Smolyansky Trust 2/2/16: 1,233,333 shares (8.1%) – sole voting and dispositive power.

In aggregate, the group controls approximately 35.1 % of the reported outstanding shares.

Purpose of Transaction: On 2 July 2025 the filing persons launched a consent solicitation seeking to:

  • Repeal any by-law amendments adopted after 24 Mar 2023.
  • Remove current directors appointed on or after 15 Jun 2024.
  • Elect seven nominees (including Edward and Ludmila Smolyansky) to the board.
  • Amend the by-laws to bar employment of the CEO’s immediate family members.

They simultaneously issued a press release (Ex. 99.1) and, on 7 July 2025, demanded that Lifeway call its 2025 Annual Meeting “as promptly as practicable.”

Implications: The filing signals an activist campaign aimed at overhauling governance, replacing directors and restricting nepotistic practices. With a combined stake above one-third of shares outstanding, the group wields significant influence that could reshape Lifeway’s board composition and corporate strategy.

Positive

  • Activist group controls ~35 % of shares, providing significant leverage to enact proposed changes.
  • Consent solicitation targets governance improvements, including board refresh and anti-nepotism by-law.

Negative

  • Potential proxy fight may create short-term uncertainty and legal costs.
  • Public dispute highlights possible governance frictions within Lifeway’s leadership.

Insights

TL;DR Activist group owning c.35 % seeks board overhaul, by-law repeal and anti-nepotism changes—high governance impact.

The Smolyansky family’s latest amendment formalises a consent solicitation targeting four governance actions: rescinding recent by-law changes, removing incumbent directors, installing seven new nominees and prohibiting employment of the CEO’s relatives. Their collective 35 % ownership gives them meaningful leverage, increasing the likelihood that proposals gain support or force negotiation. The demands focus on transparency and independence, themes generally welcomed by outside investors. However, the campaign may trigger a costly proxy fight and near-term uncertainty. Given the sizeable stake and comprehensive agenda, I classify the filing as impactful, with a positive governance bias.

TL;DR Potential catalyst: large insider bloc pushes for board change; could unlock value but adds short-term volatility.

From a portfolio perspective, a 35 % bloc initiating a consent solicitation is a clear catalyst. Board turnover and stricter by-laws may lead to strategic refocus or operational changes. Historical activism in small-cap food names often precedes cost discipline or sale processes. Still, proxy battles can distract management and weigh on sentiment. Shareholders should monitor timetable to the 2025 annual meeting and any management response. Overall, risk-reward skews modestly positive if governance reforms materialise.






If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row (11): In accordance with Rule 13d-101 under the Act, the reporting person has calculated the percentage of outstanding shares beneficially owned by her based on 15,203,241 shares reported to be outstanding as of May 6, 2025 (the "Reported Outstanding Shares"), as contained in the issuer's Quarterly Report on Form 10-Q for the period ended March 31, 2025, as filed with the Securities and Exchange Commission on May 13, 2025. The reporting person does not hereby concede that all such Reported Outstanding Shares are validly issued and outstanding, including, without limitation, any shares purported to have been issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row (11): In accordance with Rule 13d-101 under the Act, the reporting person has calculated the percentage of outstanding shares beneficially owned by him based on the Reported Outstanding Shares. The reporting person does not hereby concede that all such Reported Outstanding Shares are validly issued and outstanding, including, without limitation, any shares purported to have been issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC.


SCHEDULE 13D




Comment for Type of Reporting Person:
Note to Row (11): In accordance with Rule 13d-101 under the Act, the reporting person has calculated the percentage of outstanding shares beneficially owned by it based on the Reported Outstanding Shares. The reporting person does not hereby concede that all such Reported Outstanding Shares are validly issued and outstanding, including, without limitation, any shares purported to have been issued to Julie Smolyansky or her spouse without the consent of Danone North America PBC.


SCHEDULE 13D


Ludmila Smolyansky
Signature:/s/ Ludmila Smolyansky
Name/Title:Ludmila Smolyansky
Date:07/07/2025
Edward Smolyansky
Signature:/s/ Edward Smolyansky
Name/Title:Edward Smolyansky
Date:07/07/2025
The Edward Smolyansky Trust 2/2/16
Signature:/s/ Edward Smolyansky
Name/Title:Edward Smolyansky, Trustee
Date:07/07/2025

FAQ

How many Lifeway Foods (LWAY) shares does Edward Smolyansky currently own?

Edward Smolyansky reports 3,159,975 shares, representing 20.8 % of the outstanding stock.

What are the key proposals in the Smolyanskys’ 2025 consent solicitation for LWAY?

Repeal recent by-law changes, remove certain directors, elect seven new nominees, and ban employment of the CEO’s immediate family members.

What combined ownership percentage do the filing persons hold in Lifeway Foods?

The three reporting persons collectively control about 35.1 % of outstanding shares.

Why did the Smolyanskys request Lifeway to call the 2025 Annual Meeting promptly?

On 7 July 2025, they demanded the meeting to expedite shareholder voting on their governance proposals.

Is there a press release associated with this Schedule 13D/A filing?

Yes, a press release dated 2 July 2025 is filed as Exhibit 99.1 and incorporated by reference.
Lifeway Food

NASDAQ:LWAY

LWAY Rankings

LWAY Latest News

LWAY Latest SEC Filings

LWAY Stock Data

342.65M
5.47M
65.29%
22.35%
0.89%
Packaged Foods
Dairy Products
Link
United States
MORTON GROVE